Waldencast plc

Waldencast plc

WALD·NASDAQ

$1.71

-7.1%
TechnologySoftware - Application

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

At a Glance

Live Snapshot
Market Cap$202.19M
EPS-2.0100
P/E Ratio-0.85
Earnings Date05/11/2026
0.00%
Dividend Yield
3Y-100.0%
5Y-100.0%
10Y-100.0%
0.00%
Dividend Payout Ratio
3Y-100.0%
5Y-100.0%
10Y-100.0%
3Y-100.0%
5Y-100.0%
10Y-100.0%
Waldencast plc

Waldencast plc Dividend History

WALD · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

WALD Dividend Payment History

WALD · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
wald

Waldencast plc Payout Ratio Analysis

WALD · NASDAQ
Dividends Paid
0.00
2025
Net Income
-229.75M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.